pdufa.bio

ICOTYDE (icotrokinra)

Updated ยทnext FDA decision on the calendar

ICOTYDE (icotrokinra) 2 FDA decisions on record below. Every date links its source.

JNJ catalyst hub · PTGX catalyst hub

About this program

We track 2 catalyst events for this program: 0 upcoming and 2 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Mar 18, 2026 ✓ ApprovedJNJPDUFA · Mar 18, 2026 ✓ ApprovedPTGX

Questions

When is ICOTYDE (icotrokinra)'s next FDA decision or readout?

No upcoming catalyst is on our calendar for ICOTYDE (icotrokinra); 2 FDA decisions are on record below.

What happened at ICOTYDE (icotrokinra)'s most recent FDA decision?

On Mar 18, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.